Adial pharmaceuticals advances to second cohort in pharmacokinetics study of ad04 for the treatment of alcohol use disorder

Patient dosing in the second cohort has commenced following the successful completion of the first cohort patient dosing in the second cohort has commenced following the successful completion of the first cohort

ADIL Ratings Summary

ADIL Quant Ranking